4//SEC Filing
Tesi Raymond Joseph 4
Accession 0001213900-21-045373
CIK 0001711754other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:42 PM ET
Size
7.0 KB
Accession
0001213900-21-045373
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Exercise/Conversion
Common Stock
2021-08-25$3.91/sh+30,000$117,300→ 1,524,433 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-08-25−30,000→ 270,000 totalExercise: $3.91Exp: 2029-11-24→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]These options were exercised in a cash transaction by the Reporting Person under Rule 16(b)(3). The options were granted to the Reporting Person under the Company's 2019 Stock Incentive Plan.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767280
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 4:42 PM ET
- Size
- 7.0 KB